FKTN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Within dystroglycanopathies clinical spectrum (Godfrey et al., 2007), FKTN mutations are causative of 3 distinct phenotypes, which differ in clinical severity and CNS involvement.